These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27112900)

  • 1. Coordination and redox properties of copper interaction with α-synuclein.
    Valensin D; Dell'Acqua S; Kozlowski H; Casella L
    J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of copper-α-synuclein peptide complexes relevant to Parkinson's disease.
    Dell'Acqua S; Pirota V; Anzani C; Rocco MM; Nicolis S; Valensin D; Monzani E; Casella L
    Metallomics; 2015 Jul; 7(7):1091-102. PubMed ID: 25865825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment.
    Bacchella C; Camponeschi F; Kolkowska P; Kola A; Tessari I; Baratto MC; Bisaglia M; Monzani E; Bubacco L; Mangani S; Casella L; Dell'Acqua S; Valensin D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
    Drew SC
    Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease.
    Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
    Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
    PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation Rather than H50Q Mutation Impacts the Kinetics of Cu(II) Binding to α-Synuclein.
    Teng X; Sheveleva A; Tuna F; Willison KR; Ying L
    Chemphyschem; 2021 Dec; 22(23):2413-2419. PubMed ID: 34617653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine quinones interact with alpha-synuclein to form unstructured adducts.
    Bisaglia M; Tosatto L; Munari F; Tessari I; de Laureto PP; Mammi S; Bubacco L
    Biochem Biophys Res Commun; 2010 Apr; 394(2):424-8. PubMed ID: 20226175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration.
    Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J
    Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides, α-Synuclein, and Parkinson's Disease.
    Ledeen RW; Wu G
    Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological role of lipid interaction with α-synuclein in Parkinson's disease.
    Suzuki M; Sango K; Wada K; Nagai Y
    Neurochem Int; 2018 Oct; 119():97-106. PubMed ID: 29305919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox activity of α-synuclein-Cu is silenced by Zn₇-metallothionein-3.
    Meloni G; Vašák M
    Free Radic Biol Med; 2011 Jun; 50(11):1471-9. PubMed ID: 21320589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant?
    Bisaglia M; Bubacco L
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32013126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
    García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
    Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrolein and Copper as Competitive Effectors of α-Synuclein.
    Falcone E; Ahmed IMM; Oliveri V; Bellia F; Vileno B; El Khoury Y; Hellwig P; Faller P; Vecchio G
    Chemistry; 2020 Feb; 26(8):1871-1879. PubMed ID: 31804737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.